Amneal Pharmaceuticals, Inc. AMRX Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s income tax?
- Amneal Pharmaceuticals, Inc. (AMRX) reported income tax of $2.18M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s income tax changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s income tax decreased by 83.1% year-over-year, from $12.87M to $2.18M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s income tax?
- Over 3 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s income tax has grown at a 0.2% compound annual growth rate (CAGR), from $11.2M to $11.28M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.